Please Wait.....
Report
North America Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)
Market Report I 2022-09-12 I 173 Pages I The Insight Partners
The anti-infective agents market in North America is expected to grow from US$ 45,331.11 million in 2021 to US$ 55,179.54 million by 2028. It is estimated to grow at a CAGR of 3.1% from 2022 to 2028.
The increasing prevalence of chronic diseases is a major factor behind the growth of the North America anti-infective agents market. Chronic diseases are conditions that develop over an extended period due to a combination of genetic, physiological, environmental, and behavioral variables. The four primary categories of NCD are diabetes, cancer, chronic respiratory diseases (such as chronic obstructive pulmonary disease and asthma), and cardiovascular disorders (including heart attacks and stroke). The rising prevalence of anti-infective resistance, which has now become a public health issue, poses a hazard to human health. Anti-bacterial, anti-viral, anti-fungal, and anti-parasitic drugs are anti-infectives that work to prevent or treat infections. Antibiotics are chemically derived antimicrobial medications that cure and prevent bacterial illnesses by eradicating or preventing their growth. Azithromycin, clarithromycin, and erythromycin are examples of macrolides, which have historically been the main antibiotic classes, studied for their potential role in the secondary prevention of coronary heart diseases.
The study of cancer genesis has advanced to the cellular and molecular levels due to the rapid growth of contemporary science and technology, particularly biomedicine, in the 20th century. Modern cell biology describes malignancies as a group of biological illnesses distinguished by aberrant cell proliferation. Since every cancer begins in a single cell, cancers are also diseases that include alterations in the structure and function of genetic material. Since cancer cells proliferate, they pass on their malignant activity to their offspring (DNA). In the meantime, cancer formation and incidence are also promoted by the invasive growth and spread of cancer cells. One of the most significant classes of antibiotics with their unique inhibitory effects on malignancies is the anti-cancer class. Several antibiotics' anti-proliferative, pro-apoptotic, and anti-epithelial-mesenchymal-transition (EMT) properties have been employed in the treatment of cancer. Thus, the increasing prevalence of chronic diseases is driving the North America anti-infective agents market.
Vendors can attract new customers and expand their footprints in emerging markets with new features and technologies. This factor is likely to drive the North America anti-infective agents market at a good CAGR during the forecast period.
North America Anti-Infective Agents Market Revenue and Forecast to 2028 (US$ Million)
North America Anti-Infective Agents Market Segmentation
The North America anti-infective agents market is segmented based on type, range, route of administration, indication, distribution channel, and country. Based on type, the market is segmented into anti-bacterial, anti-viral, anti-fungal, and others. The anti-viral segment is expected to account for the largest market share by the end of 2022.
Based on range, the market is segmented into broad spectrum and narrow spectrum. By the end of 2022, the narrow spectrum segment will likely hold a larger market share.
Based on route of administration, the market is segmented into topical, oral, IV, and others. By the end of 2022, the IV segment is likely to hold the largest market share.
Based on indication, the market is segmented into HIV, tuberculosis, respiratory infection, pneumonia, and others. In 2022, the others segment is projected to hold the largest share of the market.
Based on distribution channel, the market is segmented into hospital pharmacies, specialty pharmacies, e-commerce, and others. By the end of 2022, the hospital pharmacies segment is likely to hold the largest market share.
Based on country, the market is segmented into the US, Canada, and Mexico. The US is expected to hold the largest market share by the end of 2022.
Abbott; Allergan Plc.; Astellas Pharma Inc.; Bayer AG; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd.; Gilead Sciences, Inc.; GlaxoSmithKline plc.; Merck & Co., Inc.; and Novartis AG are the leading companies in the North America anti-infective agents market.
TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Anti-Infective Agents Market - By Type
1.3.2 North America Anti-Infective Agents Market - By Range
1.3.3 North America Anti-Infective Agents Market - By Route of Administration
1.3.4 North America Anti-Infective Agents Market - By Indication
1.3.5 North America Anti-Infective Agents Market - By Distribution Channel
1.3.6 North America Anti-Infective Agents Market - By Country
2. North America Anti-Infective Agents Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Anti-infective Agents Market - Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Anti-Infectives Agents Market - Key Market Dynamics
5.1 Key Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Surging Government Support for Research Activities and Clinical Trials
5.2 Market Restraints
5.2.1 Emergence of Anti-infective Drugs Resistance and Their Side Effects
5.3 Market Opportunities
5.3.1 Development of New Anti-infective Agents
5.4 Future Trends
5.4.1 Rising Investments in R&D Activities in Pharmaceutical Sector
5.5 Impact Analysis
6. Anti-Infectives Agents Market - North America Analysis
6.1 North America Anti-Infectives Agents Market Revenue Forecast and Analysis
7. North America Anti-Infectives Agents Market Analysis and Forecast to 2028 - Type
7.1 Overview
7.2 North America Anti-infectives Agents Market, by Type, 2022 & 2028 (%)
7.3 Anti-Viral
7.3.1 Overview
7.3.2 Anti-Viral Market Revenue and Forecast to 2028 (US$ Million)
7.4 Anti-Bacterial
7.4.1 Overview
7.4.2 Anti-Bacterial Market Revenue and Forecast to 2028 (US$ Million)
7.5 Anti-Fungal
7.5.1 Overview
7.5.2 Anti-Fungal Market Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
8. North America Anti-Infectives Agents Market Analysis and Forecast to 2028 - Range
8.1 Overview
8.2 North America Anti-Infectives Agents Market, by Range, 2022 & 2028 (%)
8.3 Narrow Spectrum
8.3.1 Overview
8.3.2 Narrow Spectrum Market Revenue and Forecast to 2028 (US$ Million)
8.4 Broad Spectrum
8.4.1 Overview
8.4.2 Broad Spectrum Market Revenue and Forecast to 2028 (US$ Million)
9. North America Anti-Infectives Agents Market Analysis and Forecast to 2028 - Route of Administration
9.1 Overview
9.2 North America Anti-Infectives Agents Market, by Route of Administration, 2022 & 2028 (%)
9.3 IV
9.3.1 Overview
9.3.2 IV Market Revenue and Forecast to 2028 (US$ Million)
9.4 Oral
9.4.1 Overview
9.4.2 Oral Market Revenue and Forecast to 2028 (US$ Million)
9.5 Topical
9.5.1 Overview
9.5.2 Topical Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others Market Revenue and Forecast to 2028 (US$ Million)
10. North America Anti-Infectives Agents Market Analysis and Forecast to 2028 - Indication
10.1 Overview
10.2 North America Anti-Infectives Agents Market, by Indication, 2022 & 2028 (%)
10.3 HIV
10.3.1 Overview
10.3.2 HIV Market Revenue and Forecast to 2028 (US$ Million)
10.4 Tuberculosis
10.4.1 Overview
10.4.2 Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)
10.5 Respiratory Infection
10.5.1 Overview
10.5.2 Respiratory Infection Market Revenue and Forecast to 2028 (US$ Million)
10.6 Pneumonia
10.6.1 Overview
10.6.2 Pneumonia Market Revenue and Forecast to 2028 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)
11. North America Anti-Infectives Agents Market Analysis and Forecast to 2028 - Distribution Channel
11.1 Overview
11.2 North America Anti-Infectives Agents Market, by Distribution Channel, 2022 & 2028 (%)
11.3 Hospital Pharmacies
11.3.1 Overview
11.3.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.4 Retail Pharmacies
11.4.1 Overview
11.4.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.5 Specialty Pharmacies
11.5.1 Overview
11.5.2 Specialty Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
11.6 E-Commerce
11.6.1 Overview
11.6.2 E-Commerce Market Revenue and Forecast to 2028 (US$ Million)
11.7 Others
11.7.1 Overview
11.7.2 Others Market Revenue and Forecast to 2028 (US$ Million)
12. North America Anti-Infectives Agents Market Analysis and Forecasts To 2028 - Country Analysis
12.1 Overview
12.1.1 North America: Anti-Infective Agents Market, by Country, 2022 & 2028 (%)
12.1.1.1 US: Anti-Infective Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.1.1 Overview
12.1.1.1.2 US: Anti-Infective Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.1.3 US: Anti-Infective Agents Market, by Type, 2019-2028 (US$ Million)
12.1.1.1.4 US: Anti-Infective Agents Market, by Range, 2019-2028 (US$ Million)
12.1.1.1.5 US: Anti-Infective Agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.1.1.6 US: Anti-Infective Agents Market, by Indications, 2019-2028 (US$ Million)
12.1.1.1.7 US: Anti-Infective Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
12.1.1.2 Canada: Anti-Infective Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.2.1 Overview
12.1.1.2.2 Canada: Anti-Infective Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.2.3 Canada: Anti-Infective Agents Market, by Type, 2019-2028 (US$ Million)
12.1.1.2.4 Canada: Anti-Infective Agents Market, by Range, 2019-2028 (US$ Million)
12.1.1.2.5 Canada: Anti-Infective Agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.1.2.6 Canada: Anti-Infective Agents Market, by Indications, 2019-2028 (US$ Million)
12.1.1.2.7 Canada: Anti-Infective Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
12.1.1.3 Mexico: Anti-Infective Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.3.1 Overview
12.1.1.3.2 Mexico: Anti-Infective Agents Market - Revenue and Forecast to 2028 (US$ Million)
12.1.1.3.3 Mexico: Anti-Infective Agents Market, by Type, 2019-2028 (US$ Million)
12.1.1.3.4 Mexico: Anti-Infective Agents Market, by Range, 2019-2028 (US$ Million)
12.1.1.3.5 Mexico: Anti-Infective Agents Market, by Route of Administration, 2019-2028 (US$ Million)
12.1.1.3.6 Mexico: Anti-Infective Agents Market, by Indications, 2019-2028 (US$ Million)
12.1.1.3.7 Mexico: Anti-Infective Agents Market, by Distribution Channel, 2019-2028 (US$ Million)
13. Anti-infectives Agents Market-Industry Landscape
13.1 Overview
13.2 Growth Strategies In The Anti-infective agents Market, 2018-2022
13.3 Organic Developments
13.3.1 Overview
13.3.2 Organic Growth Strategies In The Anti-infective agents Market, 2018-2022
13.4 Inorganic Developments
13.4.1 Overview
13.4.2 Inorganic Growth Strategies In The Anti-infective agents Market, 2018-2022
14. Anti-Infectives Agents Market- Company Profiles
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Allergan Plc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Astellas Pharma Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Merck & Co., Inc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bayer AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Bristol-Myers Squibb Company
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Boehringer Ingelheim International GmbH
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 F. HOFFMANN-LA ROCHE LTD.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Gilead Sciences, Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 GlaxoSmithKline plc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Novartis AG
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. US Anti-Infective Agents Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 2. US Anti-Infective Agents Market, by Range - Revenue and Forecast to 2028 (US$ Million)
Table 3. US Anti-Infective Agents Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 4. US Anti-Infective Agents Market, by Indications - Revenue and Forecast to 2028 (US$ Million)
Table 5. US Anti-Infective Agents Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada Anti-Infective Agents Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Anti-Infective Agents Market, by Range - Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Anti-Infective Agents Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Anti-Infective Agents Market, by Indications - Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Anti-Infective Agents Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico Anti-Infective Agents Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Anti-Infective Agents Market, by Range - Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Anti-Infective Agents Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Anti-Infective Agents Market, by Indications - Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Anti-Infective Agents Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 16. Recent Inorganic Growth Strategies In The Anti-infective agents Market
Table 17. Glossary of Terms, North America Anti-infectives Agents Market
LIST OF FIGURES
Figure 1. North America Anti-Infective Agents Market Segmentation
Figure 2. North America Anti-Infective Agents Market Segmentation, by Country
Figure 3. North America Anti-infective agents Market Overview
Figure 4. Anti-Viral Segment Held Largest Share of Product Segment in North America Anti-Infective Agents Market
Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. North America Anti-Infectives Agents Market Impact Analysis of Drivers and Restraints
Figure 9. North America Anti-infectives agents Market- Revenue Forecast and Analysis - 2019 - 2028
Figure 10. North America Anti-infectives Agents Market, by Type, 2022 & 2028 (%)
Figure 11. North America Anti-Viral Market Revenue and Forecast to 2028 (US$ Million)
Figure 12. North America Anti-Bacterial Market Revenue and Forecast to 2028 (US$ Million)
Figure 13. North America Anti-Fungal Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. North America Anti-Infectives Agents Market, by Range, 2022 & 2028 (%)
Figure 16. North America Narrow Spectrum Market Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Broad Spectrum Market Revenue and Forecast to 2028 (US$ Million)
Figure 18. North America Anti-Infectives Agents Market, by Route of Administration, 2022 & 2028 (%)
Figure 19. North America IV Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. North America Oral Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America Topical Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America Anti-Infectives Agents Market, by Indication, 2022 & 2028 (%)
Figure 24. North America HIV Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. North America Tuberculosis Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. North America Respiratory Infection Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America Pneumonia Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America Anti-Infectives Agents Market, by Distribution Channel, 2022 & 2028 (%)
Figure 30. North America Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
Figure 31. North America Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
Figure 32. North America Specialty Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
Figure 33. North America E-Commerce Market Revenue and Forecast to 2028 (US$ Million)
Figure 34. North America Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 35. North America: Anti-Infective Agents Market, by Key Country - Revenue (2022) (US$ Million)
Figure 36. North America: Anti-Infective Agents Market, by Country, 2022 & 2028 (%)
Figure 37. US: Anti-Infective Agents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 38. Canada: Anti-Infective Agents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. Mexico: Anti-Infective Agents Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. Growth Strategies In The Anti-infective agents Market, 2018-2022
Figure 41. Recent Organic Growth Strategies In The Anti-infective agents Market
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security